MX2018013893A - Composicion topica estable. - Google Patents

Composicion topica estable.

Info

Publication number
MX2018013893A
MX2018013893A MX2018013893A MX2018013893A MX2018013893A MX 2018013893 A MX2018013893 A MX 2018013893A MX 2018013893 A MX2018013893 A MX 2018013893A MX 2018013893 A MX2018013893 A MX 2018013893A MX 2018013893 A MX2018013893 A MX 2018013893A
Authority
MX
Mexico
Prior art keywords
stable topical
topical composition
pharmaceutically acceptable
acceptable salts
composition
Prior art date
Application number
MX2018013893A
Other languages
English (en)
Inventor
Romero Medina Silvia
Maldonado Pérez Alejandro
Saúl Solorza Camacho Karim
De Jesús VELASCO HERNÁNDEZ Jose
Original Assignee
Productos Maver S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Productos Maver S A De C V filed Critical Productos Maver S A De C V
Priority to MX2018013893A priority Critical patent/MX2018013893A/es
Publication of MX2018013893A publication Critical patent/MX2018013893A/es
Priority to PCT/MX2019/000121 priority patent/WO2020101466A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención corresponde a una composición farmacéutica tópica estable que comprende betametasona o sus sales farmacéuticamente aceptables, indometacina o sus sales farmacéuticamente aceptables y un excipiente farmacéuticamente aceptable, la cual se caracteriza porque la composición está esencialmente libre de 4-ácido clorobenzoico; y 5-metoxi-2-metil-3-ácido indolacético.
MX2018013893A 2018-11-12 2018-11-12 Composicion topica estable. MX2018013893A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2018013893A MX2018013893A (es) 2018-11-12 2018-11-12 Composicion topica estable.
PCT/MX2019/000121 WO2020101466A1 (es) 2018-11-12 2019-11-12 Composición tópica estable

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2018013893A MX2018013893A (es) 2018-11-12 2018-11-12 Composicion topica estable.

Publications (1)

Publication Number Publication Date
MX2018013893A true MX2018013893A (es) 2019-05-13

Family

ID=67299010

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013893A MX2018013893A (es) 2018-11-12 2018-11-12 Composicion topica estable.

Country Status (2)

Country Link
MX (1) MX2018013893A (es)
WO (1) WO2020101466A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010389A1 (de) * 1994-09-30 1996-04-11 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische zusammensetzung
MXPA05010505A (es) * 2005-09-29 2007-03-28 Leopoldo Espinosa Abdala Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona.
GB0915319D0 (en) * 2009-09-03 2009-10-07 Sharma Anant Combination medicament
MX348595B (es) * 2013-08-02 2017-06-21 Laboratorio Raam De Sahuayo S A De C V Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
US9012402B1 (en) * 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation

Also Published As

Publication number Publication date
WO2020101466A1 (es) 2020-05-22

Similar Documents

Publication Publication Date Title
PH12019500579A1 (en) Pharmaceutical composition
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
NI201600098A (es) Composiciones farmacéuticas que comprenden azd9291
MX2022013612A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas.
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
AU2018231044A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
EA201792591A1 (ru) Фармацевтические препараты
MX2021002981A (es) Pirrolinas fusionadas que actuan como inhibidores de la proteasa 30 especifica de la ubiquitina (usp30).
CL2020002252A1 (es) Formulación oftálmica.
MX2016002580A (es) Combinacion de un inhibidor de alk y un inhibidor de cdk para el tratamiento de enfermedades celulares proliferativas.
WO2019073331A3 (en) Pharmaceutical compositions of apremilast
MX2022008479A (es) Combinaciones de brimonidina de dosis baja y usos de las mismas.
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
PH12016502544A1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
PH12018501285A1 (en) Alkyl dihydroquinoline sulfonamide compounds
MX2018007511A (es) Compuestos de alquinil dihidroquinolina sulfonamida.
EA202091561A1 (ru) Фармацевтическая композиция, содержащая фармацевтически приемлемую кислотно-аддитивную соль леналидомида
MX2018013893A (es) Composicion topica estable.
WO2019151964A3 (en) Orally disintegrating formulations of saxagliptin
PH12016502527B1 (en) Stabilized desmopressin
MX2021014830A (es) Conjugados de compuestos que comprenden nitrogeno heteroaromatico donador de pares de electrones pi.
EA201691763A1 (ru) Стабильная быстрорастворимая лекарственная форма, содержащая амоксициллин и клавулановую кислоту
MX2022003917A (es) Formulacion para suspension pediatrica.
CU20160048A7 (es) Formas de dosificación farmacéutica que comprenden 1-[6-(morfolin-4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-olato de sodio
WO2019151966A3 (en) Pharmaceutical tablet compositions of dabigatran